Testing women with womb cancer for Lynch syndrome

Impact: Health impacts, Economic impacts, Political impacts


All women diagnosed with womb cancer are to be offered tests for Lynch syndrome following new guidance from the National Institute for Health and Care Excellence (NICE).
This guidance is directly underpinned by our research, which found that 3% of womb cancers are Lynch syndrome-associated; women want to be tested for Lynch syndrome; and testing everyone is both clinically effective and cost-effective. We engaged with patients, support groups (Lynch syndrome-UK), gynaecological cancer charities (Eve Appeal), national and international experts (Manchester International Consensus Group) and University Policy and Communications teams to shape our research and disseminate its findings.

Category of impact

  • Health impacts
  • Economic impacts
  • Political impacts
2017 - 2021

Related information